<DOC>
	<DOCNO>NCT01228656</DOCNO>
	<brief_summary>The aim evaluate efficacy comparative isolation association Mometasone furoate + Salicylic Acid substance isolate Mometasone furoate produce Laboratory Glenmark Pharmaceuticals Ltd. patient sex , patient plaque psoriasis grade mild moderate .</brief_summary>
	<brief_title>Effectiveness Association Mometasone Furoate 0.1 % Salicylic Acid 5 % Compared With Mometasone Furoate</brief_title>
	<detailed_description>The specific objective evaluate analytical propedeutics medical improvement clinical sign symptom related plaque psoriasis . The study conduct 40 patient deal two symmetrical lesion body identify clinician party treat double-blind mometasone furoate cream contain 0.1 % another combination furoate mometasone 0.1 % + Salicylic Acid 5 % . The group patient treat must adults sex , age 18-70 year good mental physical health sign Informed Consent clinically assess dermatologist study mild plaque psoriasis moderate . The association make proposal effectiveness develop produced Laboratory Glenmark Pharmaceuticals Ltd. , well isolated version pilot ( mometasone furoate 0.1 % ) . This study characterize Phase II multicenter .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Adults sex , regardless color social class ; Age 18 old , good mental health ; Patients plaque psoriasis mild moderate ; Patients agree participate sign Informed Consent Clarified ( appendix ) ; Patients agree return followup visit . Patients make use biologics , steroid steroidal antiinflammatory nonsteroidal make use topical medication 15 day ago 30 day ago occur oral administration ; Patients expose sun 15 day study begin course . Patients make use acetaminophen ; Patients agree term describe informed consent Informed Consent ; Patients also psoriatic plaque skin disorder cause fungi bacteria make use antimycotic antibiotic ; Lions type skin damage psoriasis ; Pregnant nursing woman ; Patients use oral anticoagulant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>